Clinical Trial Update: ARIXTRA® Adherence in SVT Patients.

View source ↗

Summary

A clinical trial update reports on fondaparinux (Arixtra) adherence in patients with superficial thrombophlebitis (SVT). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Thrombophlebitis

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombosis, Venous | Status: COMPLETED